Wolters Kluwer Clinical Drug Information Used by More Than 96% of Honor Roll Hospitals in Latest U.S. News and World Report Rankings

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that its Clinical Drug Information solutions are currently used by more than 96% of hospitals achieving Honor Roll status in U.S. News & World Report’s Best Hospitals 2014-2015 and Best Children’s Hospital’s 2014-2015 rankings.

The 2014-15 hospital rankings evaluated surveys of more than 9,500 physicians across nearly 5,000 medical centers in the U.S. High scores within at least six of the 16 specialties evaluated earned 17 hospitals a place on the Honor Roll. Death rates, patient safety and hospital reputation were a few of the many factors considered.

In the category of children’s hospitals, evaluations were conducted across 10 specialties, and high scores in three or more specialties earned Honor Roll Status. Specifically, Lexicomp^®—a comprehensive drug reference solution offered through Wolters Kluwer Clinical Drug Information—is currently used by 19 of the 20 top-ranked pediatric hospitals for neonatology.

Wolters Kluwer Clinical Drug Information unites the expertise of more than 300 professionals to provide consistent drug information across its leading solutions Lexicomp, Medi-Span^® and Facts & Comparisons^®. Through the provision of innovative and reliable resources in multiple formats, these solutions help reduce errors, improve patient safety, lower system-wide costs and increase workflow efficiency throughout the continuum of care.

"In today’s performance-driven healthcare climate, hospitals must arm clinicians with the best clinical decision support tools available to drive higher quality care delivery and improved outcomes,” said Steven Kerscher, Vice President & General Manager, Clinical Drug Information, Wolters Kluwer Health, Clinical Solutions. "We are pleased to be a trusted source of information by the top hospitals in the U.S. and will continue to build upon our track record of innovation and excellence in the market.”

About Wolters Kluwer Health
Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries worldwide, clinicians rely on Wolters Kluwer Health’s market leading information-enabled tools and software solutions throughout their professional careers from training to research to practice. Major brands include Health Language^®, Lexicomp^®, Lippincott Williams & Wilkins, Medicom^®, Medi-Span^®, Medknow, Ovid^®, Pharmacy OneSource^®, ProVation^® Medical and UpToDate^®.

Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2013 annual revenues of €3.6 billion ($4.7 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Follow our official Twitter handle: @WKHealth